Underlining the benefits of exercise for people suffering from rheumatic disease, a new study presented at the European League Against Rheumatism Annual Congress (EULAR 2014) reveals that regular exercise transiently suppresses local and systemic inflammation and can help achieve clinical efficacy in rheumatic disease.
Chronic inflammation, swelling and pain in the joints characterise the more than 200 rheumatic diseases. Persistent inflammation over time can damage affected joints, but previous research has established that exercise can decrease joint inflammation in rheumatoid arthritis.
These new research findings focused on the physiological changes created by exercise and their impact on inflammation. The researchers have found that exercise generates a true biological response and induces changes on a molecular level that stimulate anti-inflammatory effects.
This in-vivo study measured the regulation and activation of NF-kB* in mice. NF-kB, a protein complex that controls many genes involved in inflammation, is found to be chronically active in many inflammatory diseases, such as inflammatory bowel disease and arthritis.
An inflammatory response was created in mice both before and after exercise through an injection of lipopolysaccharides† (LPS). The impact of exercise was measured over time following the inflammatory response.
There was a strong systemic and local inflammatory response upon injection of LPS, which was strongest at 2 hours post-injection. NF-kB activation was seen as a result of the LPS and was detected in lymphatic tissues throughout the mouse. In those groups where mice were exercised pre- and post-LPS injection, the NF-kB activation was significantly inhibited in whole-body systemic analysis.
The effect of exercise on the inhibition of NF-kB activation was identified as a transient effect, lasting only 24 hours after exercise.
The role of exercise in inhibiting NF-kB activation was linked to the suppression of multiple pro-inflammatory cytokines. Cytokines are produced by a wide range of cells including macrophages and are involved in cell signalling.Rheumatic disease is a term used to describe over 200 conditions characterised by inflammation, swelling and pain in the joints or muscles. They are leading causes of morbidity and disability, giving rise to enormous healthcare expenditures and loss of work.